RLD2007 + RLD2008

RLD2007 + RLD2008 is a **combination drug under investigation by Hanmi Pharmaceutical**. Both RLD2007 and RLD2008 are investigational agents, and combination studies involving them are focused on evaluating drug-drug interaction, pharmacokinetics, and safety in healthy adults. The specific mechanisms of action, molecular targets, and therapeutic area(s) for RLD2007 and RLD2008 have not been disclosed publicly. Trials are in early development phase, likely with oral administration. No information is available regarding the individual identities or chemical classes of RLD2007 or RLD2008, but both are considered pharmaceuticals in Hanmi Pharmaceutical’s clinical programs[1][3][9].